Hyzaar

Losartan potassium and hydrochlorothiazide, the active ingredients in Hyzaar, are an angiotensin II receptor blocker and a thiazide diuretic presented as tablets for oral use. They are prescribed to lower elevated blood pressure in adult patients with hypertension. It is indicated for patients who require combination therapy to achieve target blood pressure levels and may benefit from the synergistic action of both components.

GNH USA supplies Hyzaar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers.

Hyzaar combines an angiotensin II receptor blocker with a thiazide diuretic to manage hypertension.

Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. Hypertension with fluid retention: promotes diuresis while controlling vascular tone, helping manage edema associated with high blood pressure. High blood pressure in diabetic patients: assists in achieving target blood pressure, supporting renal protection strategies.

Hyzaar may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urination or nocturia - Electrolyte disturbances such as low potassium - Fatigue or mild weakness - Mild gastrointestinal upset

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Severe dehydration or electrolyte imbalance (hyperkalemia, hyponatremia) - Acute kidney injury or worsening renal function - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Pancreatitis

Before initiating Hyzaar, several safety considerations should be reviewed.

Renal function monitoring: assess serum creatinine and eGFR before and during therapy. Electrolyte balance: check potassium and sodium levels regularly. Hypotension risk: initiate therapy cautiously in patients prone to low blood pressure. Pregnancy and lactation: use only if clearly needed, as safety data are limited. Drug‑specific contraindications: avoid in patients with known hypersensitivity to either component. Store at room temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Hyzaar can interact with several medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Concomitant use with aliskiren in diabetic patients: increased risk of renal impairment. - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - ACE inhibitors or other ARBs: additive effect on renal function. - NSAIDs: may blunt antihypertensive response and affect renal perfusion. - Lithium: increased lithium levels and toxicity.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: blood glucose may improve, requiring dose adjustment. - Beta‑blockers: additive hypotensive effect. - Calcium channel blockers: enhanced blood pressure lowering. - Rifampin or other enzyme inducers: may reduce losartan plasma concentrations.